Sophoridine alleviates hyperalgesia and anxiety-like behavior in an inflammatory pain mouse model induced by complete freund's adjuvant

Zheng Rong,Le Yang,Yue Chen,Yan Qin,Cai-Yan Cheng,Jun Zhao,Long-Fei Li,Xue Ma,Yu-Mei Wu,Shui-Bing Liu,Yan-Ni Liang,Ming-Gao Zhao
DOI: https://doi.org/10.1177/17448069231177634
IF: 3.37
2023-05-20
Molecular Pain
Abstract:Molecular Pain, Volume 19, Issue , January-December 2023. Chronic pain, along with comorbid psychiatric disorders, is a common problem worldwide. A growing number of studies have focused on non-opioid-based medicines, and billions of funds have been put into digging new analgesic mechanisms. Peripheral inflammation is one of the critical causes of chronic pain, and drugs with anti-inflammatory effects usually alleviate pain hypersensitivity. Sophoridine (SRI), one of the most abundant alkaloids in Chinese herbs, has been proved to exert antitumor, antivirus and anti-inflammation effects. Here, we evaluated the analgesic effect of SRI in an inflammatory pain mouse model induced by complete Freund's adjuvant (CFA) injection. SRI treatment significantly decreased pro-inflammatory factors release after LPS stimuli in microglia. Three days of SRI treatment relieved CFA-induced mechanical hypersensitivity and anxiety-like behavior, and recovered abnormal neuroplasticity in the anterior cingulate cortex of mice. Therefore, SRI may be a candidate compound for the treatment of chronic inflammatory pain and may serve as a structural basis for the development of new drugs.
neurosciences
What problem does this paper attempt to address?